| Recruiting | Post-ERCP Pancreatitis - Prophylactic Measures Implementation Study (PEP-PROMIS) NCT07244432 | Branislav Kuncak | — |
| Recruiting | Monitoring of Anti-TFPI in Hemophilia NCT07101926 | Hospices Civils de Lyon | — |
| Recruiting | Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction NCT06742567 | National Institute of Cardiovascular Diseases, Pakistan | Phase 3 |
| Completed | Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes NCT07148622 | Yuzuncu Yil University | N/A |
| Unknown | Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis NCT06162819 | Shalamar Institute of Health Sciences | N/A |
| Enrolling By Invitation | L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis NCT06640296 | Istituto Giannina Gaslini | — |
| Completed | Vitamin c Supplementation in the Prevention of CRPS Following Distal Radius Fractures NCT05842395 | Damascus University | Phase 4 |
| Unknown | Study of Low Molecular Weight Heparins NCT06020560 | Herlev Hospital | Phase 4 |
| Completed | Regional and Intravenous Dexamethasone in The Prophylaxis of Rebound Pain After Supraclavicular Block in Upper NCT07074691 | Tanta University | N/A |
| Unknown | Escalating Monthly Doses of Tafenoquine in Healthy Volunteers NCT05203744 | Naval Medical Research Center | Phase 4 |
| Completed | Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW NCT04760691 | Johns Hopkins University | Phase 1 |
| Terminated | Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022) NCT04644029 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery NCT04479579 | McMaster University | Phase 4 |
| Completed | Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a NCT04652648 | Bryn Mawr Hospital | Phase 4 |
| Terminated | Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID- NCT04363827 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Phase 2 |
| Withdrawn | Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals NCT04349228 | Abderrahmane Mami Hospital | Phase 3 |
| Unknown | Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) NCT04363450 | Louisiana State University Health Sciences Center in New Orleans | Phase 3 |
| Unknown | HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial NCT04352946 | GeoSentinel Foundation | Phase 3 |
| Completed | Mesenchymal Stem Cells for the Treatment of COVID-19 NCT04573270 | Thomas Advanced Medical LLC | Phase 1 |
| Withdrawn | HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers NCT04336748 | Medical University of Vienna | Phase 3 |
| Completed | Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty NCT04079686 | Daniela Francescato Veiga | N/A |
| Recruiting | Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants NCT03717623 | Melbourne Health | Phase 4 |
| Completed | Lactobacillus Reuteri DSM 17938 in Gut Microbiota Development in Infant Born by Caesarean Section NCT03675048 | BioGaia AB | N/A |
| Completed | Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant NCT03850379 | Henry Ford Health System | Phase 2 |
| Completed | A Long Term Safety Study of BCX7353 in Hereditary Angioedema NCT03472040 | BioCryst Pharmaceuticals | Phase 2 / Phase 3 |
| Unknown | Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT NCT03395860 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Completed | Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibio NCT02951702 | St. Luke's Hospital, Chesterfield, Missouri | Phase 4 |
| Completed | The Role of Left Prefrontal Transcranial Magnetic Stimulation in Episodic Migraine Prophylaxis NCT04031781 | Ain Shams University | N/A |
| Completed | Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A NCT02362581 | Chulalongkorn University | N/A |
| Completed | Cefazolin Pharmacokinetics: Elimination Clearance in Neonates NCT01295606 | Universitaire Ziekenhuizen KU Leuven | Phase 4 |
| Completed | Discharge ALERT: Quality Improvement Initiative NCT00853463 | Brigham and Women's Hospital | N/A |
| Completed | Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to C NCT00406913 | University of Chicago | N/A |
| Approved For Marketing | Oral Berotralstat Expanded Access Program NCT04428632 | BioCryst Pharmaceuticals | — |